文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
M. Larmar
发表
Clinical Trial Results from the Subgroup of Lymphoma/CLL in a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor
A. Tolcher, K. Papadopoulos, B. Schwartz, 2015 .